Exact Sciences is paying $75 million up front for U.S. rights to a colorectal cancer blood test developed by rival Freenome. If approved, Freenome’s liquid biopsy will compete with a blood test from Guardant Health.
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.
Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice
uMETHOD, which provides precision medicine software to treat cognitive decline, tapped at-home diagnostics provider Getlabs to supply mobile phlebotomies for its patients in Arizona. Blood tests are an essential part of the personalized care plans that uMETHOD provides, and the partnership seeks to make these tests accessible to patients with cognitive decline.
The current pandemic, which has caused treatment delays, is simply another reason that home-based treatment options should become more readily available to cancer patients.
With $36 million in new funding, San Diego-based Genalyte is carrying the torch for simplified diagnostics, developing a finger-prick blood test that can deliver results in just minutes.
Also, study recommends that hospitals screen patients for dementia to reduce falls and medical device price comparisons.
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.
This work from Johns Hopkins researchers could open up access to testing in remote and poor corners of the globe, according to an article published Wednesday in the journal PLoS One.
Cleveland Diagnostics, a startup developing blood tests for a variety of cancers, just raised about $2 million, according to regulatory filing. The company spun out of Cleveland Clinic Innovations in 2013, and hasn’t announced much since. Here’s MedCity‘s take on what the startup was up to at the time: The new company is scooping up cancer diagnostic […]
Bay Area super-startup Theranos and its CEO Elizabeth Holmes have graced the New Yorker this week, in a piece that describes disruptive, futuristic medicine to the literati set. It also brings up the discrepancy between health and high tech, and how the secrecy that shrouds Theranos – and Holmes – might not be as appropriate in healthcare as […]
Download October’s Startup Index The Nokia X Sensing challenge drew 11 finalists. Each company fell into 1 of 2 groups: a do-it-all sensor or a specialized sensor. EMI, one of the multi-purpose tests, won the challenge and $525,000. One set of entrepreneurs clearly fell under the Star Trek sway – the idea of actually […]
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
The diagnostics space is choked with countless cancer tests – from biopsies and imaging analyses to a simple blood test. Bay Area startup Miroculus is working on a device that can conduct multiple cancer tests from a single blood sample. Wired wrote an in-depth profile of the company, which is worth a read. It begins: Early detection, we’re often […]
With a simple blood test, Epic Sciences can help physicians monitor the condition and severity of a cancer patient’s cancer by analyzing the intricacies of his or her circulating tumor cells. The San Diego company just raised $30 million in a Series C round to commercialize what CEO Murali Prahalad calls its “no cell left behind” diagnostic […]